Aarti Industries

The project has moved beyond technology finalization into the equipment delivery and environmental clearance stage. (1 met across 1 tracked commitment)

Management confirmed that the calcium chloride plant is expected to be commissioned within the current quarter (Q3 FY26) as previously guided. (1 met, 1 revised, 1 exceeded across 3 tracked commitments)

The project (Zone 4) is progressing as per plan with chemical charging started for specific blocks. (1 in progress across 1 tracked commitment)

Management has increased the FY26 capex guidance by 10% due to incremental requirements for MMA expansions and the PEDA project. (1 revised across 1 tracked commitment)

Contrary to the debt reduction target, working capital needs for exports have led to higher debt and finance costs in Q3. (1 missed across 1 tracked commitment)

The Energy segment (MMA) saw volumes remain flattish due to plant disruptions and Indo-Pak conflict, but the company successfully expanded capacity from 200 KTPA to 260 KTPA to maintain global leadership. (4 expanding, 1 shifted across 2 engines)

The Pharma segment share has slightly decreased, but management expects positive developments from H1-FY26 due to domestic market share gains. (1 contracting, 2 expanding, 1 stable across 1 engine)

Exports reached an all-time high of 65% of total revenue, driven by a resumption of US volumes and diversification into Europe and the Middle East. (2 expanding, 3 contracting)

The Energy segment continues to be a high-growth driver, posting 21% sequential volume growth as the company diversifies its customer base and geographical reach. (1 expanding, 2 contracting across 2 engines)

The segment share has expanded from 12% to 18% of total revenue, though management notes that pricing remains under pressure globally. (1 expanding, 1 stable, 1 shifted, 1 contracting across 1 engine)

Export traction is accelerating in specific segments like Energy & Additives (80% export) and Polymer & Additives (92% export), with a focus on diversifying the geographic base. (4 accelerating, 1 decelerating across 5 signals, 1 leading indicator)

Capex has been revised upward from Rs. 1,000 crs to Rs. 1,100 crs to fast-track high-return projects like MMA and DCB debottlenecking. (2 accelerating, 3 decelerating across 5 signals)

A new joint venture with 'Superform' is set to begin production soon, targeting the agrochemical and paint industries to diversify the company's customer base.

The company is using Artificial Intelligence (AI) across its factories to improve efficiency, reduce energy use, and lower production costs. (+2 more signals)

U.S. tariffs caused a significant volume drop in Q2, but management expects a resumption of volumes in Q3 despite ongoing uncertainty. (1 reversing across 1 signal)

Concentration in MMA has actually increased as it reached 98% capacity utilization and drove significant revenue growth this quarter. While successful, it increases sensitivity to the 'gasoline-naphtha crack' (price difference). (1 intensifying, 4 stable)

The risk is intensifying slightly as the FY26 CAPEX guidance was raised from Rs. 1,000 crs to Rs. 1,100 crs. This has already resulted in a marginal increase in debt and interest costs during Q3. (2 intensifying, 3 easing)

The risk remains stable as MMA continues to be a primary growth driver with capacity expanding from 290+ KT to 360 KT. However, management is attempting to diversify the application layer and geographic reach to Europe. (2 stable)

The risk is transitioning into a potential opportunity. Management notes that the US tariff situation on China may create new market opportunities for Indian exports due to tariff differentials. (1 easing)

The risk is stable but remains a focus. MMA volumes grew 38% over two years, but pricing is volatile and linked to gasoline/naphtha spreads which are difficult to forecast. New Chinese competition (4 lakh ton capacity) is also emerging. (1 stable)